Cargando…

Inhibitor of RAGE and glucose-induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action

The occurrence and development of hyperglycemia-induced inflammation is associated with increased expression of receptor for advanced glycation end products (RAGE) and inflammatory factors, including IL-1β, TNF-α and IL-6. Previous studies have reported that the nucleotide-binding oligomerization do...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Mengyi, Wang, Xuemei, Wang, Pin, Peng, Wei, Zhang, Bo, Guo, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453676/
https://www.ncbi.nlm.nih.gov/pubmed/32945430
http://dx.doi.org/10.3892/mmr.2020.11422
_version_ 1783575396364582912
author Jiang, Mengyi
Wang, Xuemei
Wang, Pin
Peng, Wei
Zhang, Bo
Guo, Ling
author_facet Jiang, Mengyi
Wang, Xuemei
Wang, Pin
Peng, Wei
Zhang, Bo
Guo, Ling
author_sort Jiang, Mengyi
collection PubMed
description The occurrence and development of hyperglycemia-induced inflammation is associated with increased expression of receptor for advanced glycation end products (RAGE) and inflammatory factors, including IL-1β, TNF-α and IL-6. Previous studies have reported that the nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome interacts with thioredoxin-interacting protein (TXNIP) and serves a crucial role in inflammation. FPS-ZM1 has been identified as target inhibitor of RAGE and has been shown to exert an anti-inflammatory effect in vitro. However, the underlying mechanism by which FPS-ZM1 impacts high glucose (HG)-induced inflammation in bone marrow mesenchymal stem cells (BMSCs) remains unclear. The present study explored the regulatory effect of FPS-ZM1 on HG-induced inflammation in BMSCs. Furthermore, the role of the TXNIP/NLRP3 inflammasome signaling pathway in the regulatory effects of FPS-ZM1 on HG-induced inflammation was studied. Cell viability was determined using Cell Counting Kit-8 and western blotting was used to assess the protein expression levels of RAGE. ELISA was used to determine the levels of inflammatory markers. Reverse transcription-quantitative PCR and western blotting were used to measure the mRNA and protein expression levels of TXNIP, caspase-1, thioredoxin (TRX), NLRP3 and apoptosis-related speck-like protein containing CARD (ASC). The results revealed that in BMSCs, RAGE expression was stimulated by HG, an effect which was reversed by treatment with FPS-ZM1. In addition, HG activated inflammatory factors, such as TNF-α, IL-1β and IL-6; however, their levels were suppressed when cells were treated with FPS-ZM1 or the TXNIP/NLRP3 pathway inhibitor, resveratrol (Res). Furthermore, FPS-ZM1 inhibited the mRNA and protein expression levels of TXNIP, caspase-1, NLRP3 and ASC, and promoted TRX expression, which was consistent with the effects of Res. These findings indicated that FPS-ZM1 may attenuate HG-induced inflammation in BMSCs. Furthermore, the TXNIP/NLRP3 inflammasome signaling pathway mediated the molecular mechanism underlying this effect.
format Online
Article
Text
id pubmed-7453676
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-74536762020-08-31 Inhibitor of RAGE and glucose-induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action Jiang, Mengyi Wang, Xuemei Wang, Pin Peng, Wei Zhang, Bo Guo, Ling Mol Med Rep Articles The occurrence and development of hyperglycemia-induced inflammation is associated with increased expression of receptor for advanced glycation end products (RAGE) and inflammatory factors, including IL-1β, TNF-α and IL-6. Previous studies have reported that the nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome interacts with thioredoxin-interacting protein (TXNIP) and serves a crucial role in inflammation. FPS-ZM1 has been identified as target inhibitor of RAGE and has been shown to exert an anti-inflammatory effect in vitro. However, the underlying mechanism by which FPS-ZM1 impacts high glucose (HG)-induced inflammation in bone marrow mesenchymal stem cells (BMSCs) remains unclear. The present study explored the regulatory effect of FPS-ZM1 on HG-induced inflammation in BMSCs. Furthermore, the role of the TXNIP/NLRP3 inflammasome signaling pathway in the regulatory effects of FPS-ZM1 on HG-induced inflammation was studied. Cell viability was determined using Cell Counting Kit-8 and western blotting was used to assess the protein expression levels of RAGE. ELISA was used to determine the levels of inflammatory markers. Reverse transcription-quantitative PCR and western blotting were used to measure the mRNA and protein expression levels of TXNIP, caspase-1, thioredoxin (TRX), NLRP3 and apoptosis-related speck-like protein containing CARD (ASC). The results revealed that in BMSCs, RAGE expression was stimulated by HG, an effect which was reversed by treatment with FPS-ZM1. In addition, HG activated inflammatory factors, such as TNF-α, IL-1β and IL-6; however, their levels were suppressed when cells were treated with FPS-ZM1 or the TXNIP/NLRP3 pathway inhibitor, resveratrol (Res). Furthermore, FPS-ZM1 inhibited the mRNA and protein expression levels of TXNIP, caspase-1, NLRP3 and ASC, and promoted TRX expression, which was consistent with the effects of Res. These findings indicated that FPS-ZM1 may attenuate HG-induced inflammation in BMSCs. Furthermore, the TXNIP/NLRP3 inflammasome signaling pathway mediated the molecular mechanism underlying this effect. D.A. Spandidos 2020-10 2020-08-07 /pmc/articles/PMC7453676/ /pubmed/32945430 http://dx.doi.org/10.3892/mmr.2020.11422 Text en Copyright: © Jiang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Jiang, Mengyi
Wang, Xuemei
Wang, Pin
Peng, Wei
Zhang, Bo
Guo, Ling
Inhibitor of RAGE and glucose-induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action
title Inhibitor of RAGE and glucose-induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action
title_full Inhibitor of RAGE and glucose-induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action
title_fullStr Inhibitor of RAGE and glucose-induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action
title_full_unstemmed Inhibitor of RAGE and glucose-induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action
title_short Inhibitor of RAGE and glucose-induced inflammation in bone marrow mesenchymal stem cells: Effect and mechanism of action
title_sort inhibitor of rage and glucose-induced inflammation in bone marrow mesenchymal stem cells: effect and mechanism of action
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453676/
https://www.ncbi.nlm.nih.gov/pubmed/32945430
http://dx.doi.org/10.3892/mmr.2020.11422
work_keys_str_mv AT jiangmengyi inhibitorofrageandglucoseinducedinflammationinbonemarrowmesenchymalstemcellseffectandmechanismofaction
AT wangxuemei inhibitorofrageandglucoseinducedinflammationinbonemarrowmesenchymalstemcellseffectandmechanismofaction
AT wangpin inhibitorofrageandglucoseinducedinflammationinbonemarrowmesenchymalstemcellseffectandmechanismofaction
AT pengwei inhibitorofrageandglucoseinducedinflammationinbonemarrowmesenchymalstemcellseffectandmechanismofaction
AT zhangbo inhibitorofrageandglucoseinducedinflammationinbonemarrowmesenchymalstemcellseffectandmechanismofaction
AT guoling inhibitorofrageandglucoseinducedinflammationinbonemarrowmesenchymalstemcellseffectandmechanismofaction